OSLO, Norway, May 23, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), held its annual general meeting on 23 May 2024 at 17:00 hours (CEST).

The minutes from the general meeting setting out the resolutions are attached hereto.

For further information, please contact:

Photocure

CFO Erik Dahl
Tel: + 47 450 55 000
Email: ed@photocure.no

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/photocure/r/photocure-asa---annual-general-meeting-held,c3987214

The following files are available for download:


     
     https://mb.cision.com/Main/17498/3987214/2818495.pdf            
     Release



     
     https://mb.cision.com/Public/17498/3987214/99e08bc3bc8b3695.pdf   Photocure ASA -Minutes from AGM
                                                                           2024

View original content:https://www.prnewswire.co.uk/news-releases/photocure-asa--annual-general-meeting-held-302154595.html

Tags

More Like This

Photocure ASA - Notice of the Annual General Meeting 23 May 2024

Photocure ASA: Annual Report 2023

Photocure ASA: Change of Board Composition

Photocure to present at four investor conferences in November/December 2023

Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Photocure ASA: Results for the first quarter of 2025

Photocure ASA: Results for the second quarter of 2024

Navamedic ASA: Minutes of Annual General Meeting